13F HOLDINGS REPORT
JOHNSON & JOHNSON
Quarter ended Q2 2023 · Filed May 11, 2023 · Accession 0000904454-23-000307
Total Value
$307.4M
Positions
23
Other Managers
1
Confidential Omitted
No
Holdings (23)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Legend Biotech Corporation | LEGN | 1,629,173 | $78.6M | 25.55% |
| 2 | Protagonist Therapeutics Inc. | PTGX | 2,449,183 | $56.3M | 18.32% |
| 3 | MeiraGTx Holdings plc | MGTX | 6,641,064 | $34.3M | 11.17% |
| 4 | CVRx, Inc. | CVRX | 3,495,575 | $32.6M | 10.60% |
| 5 | Xencor, Inc. | XNCR | 748,062 | $20.9M | 6.79% |
| 6 | Fate Therapeutics, Inc. | FATE | 3,379,064 | $19.3M | 6.27% |
| 7 | Fusion Pharmaceuticals Inc. | 36118A100 | 3,670,516 | $13.8M | 4.50% |
| 8 | Procept BioRobotics Corporation | PRCT | 357,939 | $10.2M | 3.31% |
| 9 | Cue Health, Inc. | 229790100 | 5,548,864 | $10.1M | 3.29% |
| 10 | Point Biopharma Global Inc. | 730541109 | 1,000,000 | $7.3M | 2.36% |
| 11 | Arrowhead Pharmaceuticals, Inc. | ARWR | 247,598 | $6.3M | 2.05% |
| 12 | Vor Biopharma, Inc. | VOR | 1,074,658 | $5.8M | 1.88% |
| 13 | Adicet Bio, Inc. | ACET | 728,944 | $4.2M | 1.37% |
| 14 | Aldeyra Therapeutics, Inc. | ALDX | 394,834 | $3.9M | 1.28% |
| 15 | Nano-X Imaging Ltd. | NNOX | 317,704 | $1.8M | 0.60% |
| 16 | SomaLogic, Inc. | 83444K105 | 281,052 | $716,683 | 0.23% |
| 17 | BiomX Inc. | PHGE | 2,133,402 | $650,688 | 0.21% |
| 18 | Apollomics, Inc. | APLMW | 13,252 | $320,698 | 0.10% |
| 19 | Clearside Biomedical, Inc. | CLSDQ | 169,629 | $176,414 | 0.06% |
| 20 | Tracon Pharmaceuticals, Inc. | 89237H209 | 84,003 | $158,766 | 0.05% |
| 21 | Senseonics Holdings, Inc. | SENS | 54,621 | $38,781 | 0.01% |
| 22 | VistaGen Therapeutics, Inc. | VTGN | 190,494 | $23,755 | 0.01% |
| 23 | Catalyst Biosciences, Inc. | 14888D208 | 66,951 | $13,859 | 0.00% |